The store will not work correctly when cookies are disabled.
(2-Chloro-7,7-dioxo-4,7-dihydro-1,7lambda*6*-dithia-4,6-diaza-inden-5-yl)-(1-methyl-cyclobutyl)-amine
ID: ALA134168
PubChem CID: 135406970
Max Phase: Preclinical
Molecular Formula: C10H12ClN3O2S2
Molecular Weight: 305.81
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: CC1(NC2=NS(=O)(=O)c3sc(Cl)cc3N2)CCC1
Standard InChI: InChI=1S/C10H12ClN3O2S2/c1-10(3-2-4-10)13-9-12-6-5-7(11)17-8(6)18(15,16)14-9/h5H,2-4H2,1H3,(H2,12,13,14)
Standard InChI Key: IYANXPKCSGLCRO-UHFFFAOYSA-N
Molfile:
RDKit 2D
18 20 0 0 0 0 0 0 0 0999 V2000
5.1292 -4.2750 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
4.6417 -3.6292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9375 -4.1792 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.9667 -2.8792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.2542 -3.4292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8292 -3.5542 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
4.3500 -2.3417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7667 -2.7792 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.6500 -2.7667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2500 -4.4917 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.5667 -5.0417 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.0625 -3.3375 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.5542 -3.9917 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9000 -2.4417 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
7.9292 -3.2542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.2875 -4.3667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.6625 -3.6292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.5375 -4.6417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 1 1 0
4 2 2 0
5 3 2 0
6 2 1 0
7 4 1 0
8 5 1 0
9 6 1 0
10 1 2 0
11 1 2 0
12 5 1 0
13 12 1 0
14 9 1 0
15 13 1 0
16 13 1 0
17 16 1 0
18 13 1 0
4 8 1 0
7 9 2 0
17 15 1 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 305.81 | Molecular Weight (Monoisotopic): 305.0059 | AlogP: 2.40 | #Rotatable Bonds: 1 |
Polar Surface Area: 70.56 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 13.19 | CX Basic pKa: 1.53 | CX LogP: 2.30 | CX LogD: 2.30 |
Aromatic Rings: 1 | Heavy Atoms: 18 | QED Weighted: 0.84 | Np Likeness Score: -0.66 |
References
1. Nielsen FE, Bodvarsdottir TB, Worsaae A, MacKay P, Stidsen CE, Boonen HC, Pridal L, Arkhammar PO, Wahl P, Ynddal L, Junager F, Dragsted N, Tagmose TM, Mogensen JP, Koch A, Treppendahl SP, Hansen JB.. (2002) 6-Chloro-3-alkylamino-4H-thieno[3,2-e]-1,2,4-thiadiazine 1,1-dioxide derivatives potently and selectively activate ATP sensitive potassium channels of pancreatic beta-cells., 45 (19): [PMID:12213059] [10.1021/jm0208121] |
2. Nielsen FE, Ebdrup S, Jensen AF, Ynddal L, Bodvarsdottir TB, Stidsen C, Worsaae A, Boonen HC, Arkhammar PO, Fremming T, Wahl P, Kornø HT, Hansen JB.. (2006) New 3-alkylamino-4H-thieno-1,2,4-thiadiazine 1,1-dioxide derivatives activate ATP-sensitive potassium channels of pancreatic beta cells., 49 (14): [PMID:16821773] [10.1021/jm060042j] |